Apogee director granted deferred stock units

Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Alvord Christina M reported acquisition or exercise transactions in this Form 4 filing.

Apogee Enterprises director Christina M. Alvord received a grant of deferred restricted stock units. She was awarded 84 deferred restricted stock units at a reference value of $33.54 per unit, each settling 1-for-1 into common stock. After this award, she holds 10,539 deferred restricted stock units directly. These units were granted under the 2019 Non-Employee Director Stock Plan and will be settled in shares of common stock after she leaves the Board or upon other events specified in the plan, consistent with her prior deferral elections and dividend reinvestment features.

Insider Trade Summary

Grant/Award: 84 shares

Grant/Award 1 txn

Insider Alvord Christina M

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Deferrred Restricted Stock Units	84	$33.54	$3K

Holdings After Transaction: Deferrred Restricted Stock Units — 10,539 contracts (Direct)

Footnotes (3)

1. F1. Settled 1-for-1.
2. F2. Additional deferred restricted stock units were allocated pursuant to a dividend reinvestment feature of the 2019 Non-Employee Director Stock Plan.
3. F3. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Key Figures

Deferred RSUs granted: 84 units Grant reference price: $33.54 per unit Total deferred RSUs after grant: 10,539 units +2 more

5 metrics

Deferred RSUs granted 84 units Grant of deferred restricted stock units on March 31, 2026

Grant reference price $33.54 per unit Transaction price per deferred restricted stock unit

Total deferred RSUs after grant 10,539 units Holdings following the reported transaction

Underlying common stock 84 shares Common shares underlying the new deferred restricted stock units

Conversion price $0.00 Conversion or exercise price of the deferred restricted stock units

Key Terms

Deferred Restricted Stock Units, 2019 Non-Employee Director Stock Plan, dividend reinvestment feature, settled in shares of common stock

4 terms

Deferred Restricted Stock Units financial

"Deferrred Restricted Stock Units"

Deferred restricted stock units are promises by a company to give employees or executives company shares at a future date, subject to conditions like continued employment or performance targets; the delivery and tax event are intentionally delayed. They matter to investors because they affect when new shares may be issued and how executives are motivated—like a paycheck held in escrow that vests over time, influencing potential share dilution and management behavior.

2019 Non-Employee Director Stock Plan financial

"allocated under the 2019 Non-Employee Director Stock Plan"

dividend reinvestment feature financial

"allocated pursuant to a dividend reinvestment feature of the 2019"

settled in shares of common stock financial

"will be settled in shares of common stock following the director's"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Apogee (APOG) director Christina Alvord report in this Form 4 filing?

Director Christina M. Alvord reported receiving 84 deferred restricted stock units as a compensation award. These units convert 1-for-1 into Apogee common stock and increase her total deferred restricted stock unit holdings to 10,539 under the 2019 Non-Employee Director Stock Plan.

How many Apogee deferred restricted stock units does Christina Alvord now hold?

Following the latest grant, Christina M. Alvord holds 10,539 deferred restricted stock units. This total includes the newly awarded 84 units and prior allocations under Apogee’s 2019 Non-Employee Director Stock Plan, including additions from the plan’s dividend reinvestment feature over time.

What are Apogee deferred restricted stock units and how are they settled?

Apogee deferred restricted stock units are derivative awards that convert into common stock on a 1-for-1 basis. For Christina Alvord, these units will be settled in Apogee common shares after her Board service ends or upon other specified plan events, according to her deferral election.

At what value were Christina Alvord’s new Apogee deferred stock units recorded?

The 84 new deferred restricted stock units for Christina Alvord were recorded at $33.54 per unit. While this price appears in the filing, the units themselves have a $0.00 conversion price and are ultimately settled in shares of Apogee common stock on a 1-for-1 basis.

Does this Apogee Form 4 indicate open-market buying or selling by the director?

No, the Form 4 reflects a compensation-related grant, not market trading. Christina Alvord’s 84 deferred restricted stock units are classified as a grant or award acquisition, with no open-market purchases or sales reported, and are governed by the company’s 2019 Non-Employee Director Stock Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/01/2026 - 05:19 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Alvord Christina M

(Last) (First) (Middle)

C/O APOGEE ENTERPRISES, INC.

4400 WEST 78TH STREET, SUITE 520

(Street)

MINNEAPOLIS MINNESOTA 55435

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
APOGEE ENTERPRISES, INC. [ APOG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferrred Restricted Stock Units	(1)	03/31/2026		A(2)		84		(3)	(3)	Common Stock	84	$33.54	10,539	D

Explanation of Responses:

1. Settled 1-for-1.

2. Additional deferred restricted stock units were allocated pursuant to a dividend reinvestment feature of the 2019 Non-Employee Director Stock Plan.

3. The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person, or following the occurrence of other events specified in the Plan.

Remarks:

	/s/ David Wright Walstrom, Attorney-in-Fact for Christina M. Alvord	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)